Fagron N.V.
A global pharmaceutical compounding company focused on personalized medicine.
FAGR | BR
Overview
Corporate Details
- ISIN(s):
- BE0003874915
- LEI:
- 549300TRKRUFK2RRG779
- Country:
- Belgium
- Address:
- Venecoweg 20A, 9810 Nazareth
- Website:
- https://fagron.com/
- Sector:
- Manufacturing
Description
Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-04-15 08:19 |
Convocation annual general meeting and extraordinary meeting
|
English | 197.3 KB | ||
| 2019-04-12 21:00 |
Fagron NV 2019 - Verslag Art 596 opheffing voorkeurrecht v2.pdf
|
Dutch | 313.9 KB | ||
| 2019-04-12 21:00 |
Bijzonder verslag WP 2019 v2.pdf
|
Dutch | 381.7 KB | ||
| 2019-04-12 21:00 |
NE Volmacht AVA en BAV 13 mei 2019.pdf
|
Dutch | 94.7 KB | ||
| 2019-04-12 21:00 |
ENG Proxy AGM and EGM 13 May 2019.pdf
|
English | 94.4 KB | ||
| 2019-04-12 21:00 |
Fagron NV 2019 - Verslag art 596 - FULL.pdf
|
Dutch | 636.8 KB | ||
| 2019-04-12 21:00 |
ENG Background information for shareholders AGM and EGM 13 May 2019.pdf
|
English | 61.9 KB | ||
| 2019-04-12 21:00 |
Bijzonder verslag RvB WP 2019.pdf
|
Dutch | 382.6 KB | ||
| 2019-04-12 21:00 |
ENG Proxy AGM and EGM 13 May 2019.pdf
|
English | 94.4 KB | ||
| 2019-04-12 21:00 |
WP 2019.pdf
|
Dutch | 115.2 KB | ||
| 2019-04-12 21:00 |
Convocation and agenda 120419 ENG.pdf
|
English | 197.3 KB | ||
| 2019-04-12 21:00 |
Oproeping en agenda 120419 NED.pdf
|
Dutch | 197.0 KB | ||
| 2019-04-12 21:00 |
Annual report 2018 final June 2019.pdf
|
English | 6.9 MB | ||
| 2019-04-12 21:00 |
Jaarverslag 2018 finaal.pdf
|
Dutch | 7.3 MB | ||
| 2019-04-12 08:18 |
Fagron continued strong turnover growth in first quarter 2019
|
English | 292.9 KB |
Automate Your Workflow. Get a real-time feed of all Fagron N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fagron N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fagron N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Pulido Andrew | Executive member | Sell | 85,000 | 1,803,351.50 EUR |
| 2025-05-22 | Pulido Andrew | Executive member | Buy | 85,000 | 1,617,550.00 EUR |
| 2025-05-02 | De Jong Cornelia Neeltje | Board | Sell | 12,689 | 263,834.55 EUR |
| 2025-04-30 | De Jong Cornelia Neeltje | Board | Sell | 229 | 4,660.15 EUR |
| 2025-04-29 | De Jong Cornelia Neeltje | Board | Sell | 10,000 | 201,500.00 EUR |
| 2025-03-28 | J. Verlinden | Other | Buy | 24,551 | 453,702.48 EUR |
| 2025-03-28 | J. Verlinden | Other | Sell | 17,930 | 344,047.56 EUR |
| 2025-03-27 | Padilla Rafael | Board | Buy | 78,469 | 1,450,107.12 EUR |
| 2025-03-27 | De Jong Cornelia Neeltje | Board | Buy | 45,418 | 839,324.64 EUR |
| 2025-02-21 | Bakker Vera | Executive member | Buy | 773 | 15,000.00 EUR |
Peer Companies
